[The effect of a new broad-spectrum antibiotic in bronchopulmonar and urinary infections (author's transl)].
117 clinical patients with infections of the urinary tract (nequals 47) or the bronchopulmonar system (n equals 70) were treated with a Sulfamoxol-Trimethoprim-combination in low dosage for 11 days. The clinical and bacteriological results were good in more than 80 p.c. although the diseases were severe and chronic. Therefore it can be stated that Sulfamoxol-Trimethoprim is comparable to the broad-spectrum antibiotics with respect to the antibacterial efficacy. Side-effects did not occur.
D000293:Adolescent; D000368:Aged; D001799:Blood Sedimentation; D055598:Chemical Phenomena; D002621:Chemistry; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007962:Leukocytes; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013423:Sulfamoxole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D004338:Drug Combinations; D014295:Trimethoprim; D013423:Sulfamoxole
Zur Wirkung eines neuen Breitspektrumchemotherapeutikums bei Erkrankungen des Bronchopulmonal- und des Urogenitalsystems